My watch list
my.chemeurope.com  
Login  

BASF Venture Capital invests in North American investment fund ARCH Venture Fund VII

12-Dec-2007

BASF Venture Capital America Inc., Fremont, CA, has invested in ARCH Venture Fund VII - a venture capital fund managed by ARCH Venture Partners, Chicago, IL. ARCH invests at a very early stage in start-up companies from the material science, life science, as well as information technology and biotechnology sectors in North America. The majority of these start-ups have been spun off from universities or national research laboratories. The total volume of the ARCH fund will be roughly $400 million fund. BASF Venture Capital will invest $5 million. Other investors in the fund are primarily universities, pension funds and financial institutions.

"ARCH is one of the most-respected venture capital funds in the U.S., supported by an impressive management team. ARCH will complement our strategy of investing in innovative companies that are active in BASF Group's five growth clusters - energy management, raw material change, nanotechnology plant biotechnology and white (industrial) biotechnology," said Keith Gillard, Principal of BASF Venture Capital America.

In addition, BASF will benefit from ARCH's excellent network of more than fifty North American universities and national laboratories. This will allow BASF Venture Capital to gain information about new technology trends and attractive potential investments at an early stage.

Facts, background information, dossiers
More about BASF
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE